Hokkaido University · Faculty of Pharmaceutical Sciences / Graduate School of Pharmaceutical Sciences

Research keywordsneuropharmacology・bipolar disorder genetics・TRPM7 signaling・hippocampal excitability・glioblastoma targeting

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Recovery from the damage of cranial radiation modulated by memantine, an NMDA receptor antagonist, combined with hyperbaric oxygen therapy.2023 · Neuro-oncology, 25, 1, 108, 122, 2023年01月05日,
• Altered Calcium Permeability of AMPA Receptor Drives NMDA Receptor Inhibition in the Hippocampus of Murine Obesity Models.2022 · Molecular neurobiology, 59, 8, 4902, 4925, 2022年08月,
• Haplotype phasing of a bipolar disorder pedigree revealed rare multiple mutations of SPOCD1 gene in the 1p36-35 susceptibility locus.2022 · Journal of affective disorders, 310, 96, 105, 2022年08月01日,
• Generation of four iPSC lines from a family harboring a 1p36-35 haplotype linked with bipolar disorder and recurrent depressive disorder: Three-generation patients and a healthy sibling.2022 · Stem cell research, 64, 102915, 102915, 2022年10月,

• Official profile